GenMD is a Palo Alto-based company that generates privacy-preserving synthetic healthcare data using artificial intelligence. The firm, which emerged from research within Stanford Medicine and was founded by its former Director of AI, builds digital twins of real patient data. These synthetic datasets are designed to retain the statistical structure and utility of the original records without containing identifiable patient information.
The company's platform addresses a significant bottleneck in healthcare innovation: an estimated 97% of healthcare data remains unused, largely due to privacy constraints. By transforming sensitive patient records into high-fidelity synthetic equivalents, GenMD enables researchers and organisations in healthcare, pharmaceuticals, and medical research to work with realistic data while mitigating privacy risks.
GenMD operates with an intentionally small team, a structure that the company says supports high ownership and a fast pace of development. Its core technical domains include AI, digital twins, synthetic data generation, and privacy-preserving data techniques.
